---
title: "Li Bang Pharma-B rises 10% to HK$31.18"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292014901.md"
description: "Li Bang Pharma-B (9637.HK) rose 9.6% during regular trading to HK$31.18, with no specific catalysts."
datetime: "2026-07-08T05:10:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292014901.md)
  - [en](https://longbridge.com/en/news/292014901.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292014901.md)
generator: "portal-rs"
---

# Li Bang Pharma-B rises 10% to HK$31.18

Li Bang Pharma-B (9637.HK) **surged** **9.6%** during regular trading to **HK$31.18**.

No obvious catalysts were reported.

### Related Stocks

- [09637.HK](https://longbridge.com/en/quote/09637.HK.md)

## Related News & Research

- [FCNR(B) deposits cross $127 bn: Why margin worries may be overdone](https://longbridge.com/en/news/297987727.md)
- [J&T Global Express grants 45,696,708 Class B share awards under 2024 incentive scheme](https://longbridge.com/en/news/298037641.md)
- [RemeGen Deploys Idle Funds Into Discloseable Wealth Management Products](https://longbridge.com/en/news/297779978.md)
- [Earth Science Tech (ETST) Shareholders Approve Uplisting Strategy, Series B Preferred Stock Retirement](https://longbridge.com/en/news/297810754.md)
- [08:42 ETThe Nonprofit-TPA Model is the Future of Healthcare](https://longbridge.com/en/news/297916289.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**